S-phase – an independent prognostic marker in upper tract urothelial carcinoma

References

• Keeley FX, Kulp DA, Bibbo M, et al. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol. 1997;157(1):33–37. Jan
   PubMed Web of Science ®Google Scholar
• Williams SK, Denton KJ, Minervini A, et al. Correlation of Upper-Tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of Upper-Tract transitional cell carcinoma. J Endourol. 2008;22(1):71–76. Jan
   PubMed Web of Science ®Google Scholar
• Holmäng S, Johansson SL. Urothelial carcinoma of the upper urinary tract: Comparison between the who/isup 1998 consensus classification and who 1999 classification system. Urology. 2005;66(2):274–278. Aug
   PubMed Web of Science ®Google Scholar
• Malm C, Grahn A, Jaremko G, et al. Diagnostic accuracy of upper tract urothelial carcinoma: How samples are collected matters. Scand J Urol. 2017;51(2):137–145.
   PubMed Web of Science ®Google Scholar
• van Rhijn BWG, Hentschel AE, Bründl J, et al. Prognostic value of the Who1973 and Who2004/2016 classification systems for grade in primary ta/t1 Non-Muscle-invasive bladder cancer: a multicenter european association of urology Non-Muscle-invasive bladder cancer guidelines panel study. Eur Urol Oncol. 2021; 044(2):182–191.
   Google Scholar
• Rouprêt M, Babjuk M, Burger M, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol. 2021; 0179(1):62–79.
   Google Scholar
• Cutress ML, Stewart GD, Zakikhani P, et al. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (utuc): systematic review. BJU Int. 2012;110(5):614–628. Sep
   PubMed Web of Science ®Google Scholar
• Seisen T, Peyronnet B, Dominguez-Escrig JL, et al. Oncologic outcomes of Kidney-Sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the eau Non-Muscle invasive bladder cancer guidelines panel. Eur Urol. 2016; 1270(6):1052–1068.
   Google Scholar
• Birtle A, Johnson M, Chester J, et al. Adjuvant chemotherapy in upper tract urothelial carcinoma (the pout trial): a phase 3, Open-Label, randomised controlled trial. Lancet. 2020; 04 18395(10232):1268–1277.
   Google Scholar
• Almås B, Halvorsen OJ, Johannesen TB, et al. Higher than expected and significantly increasing incidence of upper tract urothelial carcinoma. A population based study. World J Urol. 2021;39(9):3385–3391. Sep
   PubMed Web of Science ®Google Scholar
• van Doeveren T, van der Mark M, van Leeuwen PJ, et al. Rising incidence rates and unaltered survival rates for primary upper urinary tract urothelial carcinoma: a dutch population‐based study from 1993 to 2017. BJU Int. 2021;128(3):343–351.
   PubMed Web of Science ®Google Scholar
• Malm C, Grahn A, Jaremko G, et al. Predicting invasiveness and Disease-Specific survival in upper tract urothelial carcinoma: Identifying relevant clinical tumour characteristics. World J Urol. 2019;37(11):2335–2342.
   PubMed Web of Science ®Google Scholar
• Bossuyt PM, Reitsma JB, Bruns DE, STARD Group, et al. Stard 2015: an updated list of essential items for reporting diagnostic accuracy studies. Clin Chem. 2015;61(12):1446–1452. Dec
   PubMed Web of Science ®Google Scholar
• Heiden T, Wang N, Tribukait B. An improved hedley method for preparation of Paraffin-Embedded tissues for flow cytometric analysis of ploidy and S-Phase. Cytometry. 1991;12(7):614–621.
   PubMedGoogle Scholar
• Margulis V, Shariat SF, Matin SF, the Upper Tract Urothelial Carcinoma Collaboration, et al. Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer. 2009;115(6):1224–1233. Mar 15
   PubMed Web of Science ®Google Scholar
• Rosiello G, Palumbo C, Knipper S, et al. Contemporary conditional Cancer-Specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract. J Surg Oncol. 2020;121(7):1154–1161. Jun
   PubMed Web of Science ®Google Scholar
• Rouprêt M, Hupertan V, Seisen T, French National Database on Upper Tract Tumors, et al. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: Development of an optimized postoperative nomogram using decision curve analysis. J Urol. 2013; May189(5):1662–1669.
   PubMed Web of Science ®Google Scholar
• Deliveliotis C, Georgoulakis J, Skolarikos A, et al. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder. Urol Res. 2005;33(1):39–43.
   PubMedGoogle Scholar
• Lipponen PK, Eskelinen MJ, Nordling S. Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S-Phase fraction and DNA ploidy. Eur J Cancer. 1991;27(7):877.
   PubMed Web of Science ®Google Scholar
• Lipponen PK, Eskelinen MJ, Collan Y, et al. DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (who). Urol Int. 1990;45(1):4–9.
   PubMed Web of Science ®Google Scholar
• Oldbring J, Hellsten S, Lindholm K, et al. Flow DNA analysis in the characterization of carcinoma of the renal pelvis and ureter. Cancer. 1989;64(10):2141–2145.
   PubMed Web of Science ®Google Scholar
• Thalmann GN, Markwalder R, Walter B, et al. Long-Term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol. 2002;168(4 Part 1):1381–1385. Oct
   PubMed Web of Science ®Google Scholar
• Schwartzmann I, Pastore AL, Sacca A, et al. Upper urinary tract urothelial carcinoma tumor seeding along percutaneous nephrostomy track: Case report and review of the literature. Urol Int. 2017;98(1):115–119.
   PubMed Web of Science ®Google Scholar
• Grahn A, Eisfeldt J, Malm C, et al. Genomic profile - a possible diagnostic and prognostic marker in upper tract urothelial carcinoma. BJU Int. 2022;130(1):92–101.
   PubMed Web of Science ®Google Scholar